Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysisY Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, Lille, France
Clin Infect Dis 36:86-96. 2003
..Prophylaxis against fungal and cytomegalovirus infections is less cost-effective than are other therapeutic options for HIV disease and should remain of lower priority...
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysisYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, France
AIDS 19:1299-308. 2005
..In 2000, WHO/UNAIDS recommended co-trimoxazole prophylaxis for persons at early stages of HIV infection (WHO stage > or = 2) in sub-Saharan Africa...
[Morbidity and cost of rotavirus infections in France]H Melliez
Service universitaire régional de maladies infectieuses, Faculte de Medecine de Lille, 135, rue du Président Coty, BP 619, 59208 Tourcoing cedex, France
Med Mal Infect 35:492-9. 2005
..Rotavirus is the most common cause of severe diarrhea in children. Morbidity and mortality related to rotavirus infection is not well known in temperate countries in general, and in France in particular...
[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]Y Yazdanpanah
Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing
Rev Epidemiol Sante Publique 54:1S23-1S31. 2006
..The objective of this study was to assess potential risk factors for Hepatitis C seroconversion after occupational exposure to HCV...
Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infectionsS Nguyen
Department of Infectious Diseases, Dron Hospital of Tourcoing, Tourcoing, France
Clin Microbiol Infect 15:1163-9. 2009
..However, the lower cost of cotrimoxazole compared with linezolid renders RCC an attractive treatment alternative to RLC. Further larger clinical studies are warranted to confirm these preliminary results...
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007Bakhao Ndiaye
CIRE Nord, Lille, France
BMC Infect Dis 11:11. 2011
....
Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIVJennifer Chu
Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, USA
AIDS Res Ther 8:14. 2011
..abstract:..
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohortsY Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Centre Hospitalier Regional Universitaire de Lille, Tourcoing, France
Int J Epidemiol 30:864-71. 2001
..The objective of this study was to estimate the incidence of primary opportunistic infections in HIV-infected individuals in geographically distinct cohorts in France...
Multidrug resistance: a clinical approachYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing and EA 2694, Faculte de Medecine de Lille, Tourcoing, France
Curr Opin HIV AIDS 4:499-506. 2009
..This review discusses the challenges that these new agents pose for the management of treatment-experienced patients...
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control studyY Yazdanpanah
Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, Tourcoing, France
Clin Infect Dis 41:1423-30. 2005
..Additional studies are required to identify risk factors for hepatitis C virus (HCV) transmission to health care workers after occupational exposure to HCV...
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trialsYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France
Antivir Ther 15:351-61. 2010
..We simulated continuous ART and STI strategies with higher CD4+ T-cell interruption/reintroduction thresholds than those assessed in actual trials...
Routine HIV screening in France: clinical impact and cost-effectivenessYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France
PLoS ONE 5:e13132. 2010
..Although previous studies have evaluated the cost-effectiveness of routine HIV screening in the United States, differences in both the epidemiology of infection and HIV testing behaviors warrant a setting-specific analysis for France...
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialY Yazdanpanah
Hôpital Tourcoing, Lille School of Medicine, Lille, France
Clin Infect Dis 49:1441-9. 2009
..The aim of this study was to assess the safety and efficacy of a regimen containing raltegravir, etravirine, and darunavir/ritonavir for treatment-experienced patients infected with multidrug-resistant HIV...
Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trialsYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, BP 619, F 59208 Tourcoing, France
BMJ 328:249. 2004
..To compare the clinical efficacy of triple antiretroviral regimens based on protease inhibitors and non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs) in adults positive for antibodies to HIV-1...
Earlier testing for HIV--how do we prevent late presentation?Yazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France
Antivir Ther 15:17-24. 2010
..They should also take advantage of rapid testing technologies and be aware of barriers to HIV testing among specific groups to provide opportunities for testing that are relevant to local communities...
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approachY Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Tourcoing, France
HIV Med 8:439-50. 2007
..Our objectives were to estimate the long-term effectiveness, cost and cost-effectiveness of genotype testing in patients with extensive antiretroviral exposure...
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapyYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, France
Antivir Ther 7:257-66. 2002
..To estimate the treatment and health care costs of HIV infection or AIDS in France during the era of highly active antiretroviral therapy (HAART)...
[Antiretroviral drugs in severe acute respiratory syndrome]Yazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille
Presse Med 35:105-7. 2006
..The epidemiologic methods used to assess this drug's efficacy are not robust. Preliminary results for SARS treatment with protease and entry inhibitors, although at early stages of development, are promising...
Cost and cost-effectiveness of childhood vaccination against rotavirus in FranceH Melliez
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France
Vaccine 26:706-15. 2008
..To assess the effectiveness and cost-effectiveness of routine childhood vaccination by new vaccines against rotavirus in France...
Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998B Lebouche
Department of Infectious Diseases, Tourcoing AIDS Reference Center, Dron Hospital, Tourcoing, France
HIV Med 7:140-5. 2006
..To determine the incidence rate and risk factors for loss to follow-up (LFU) in HIV-infected individuals...
Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infectionS Deuffic-Burban
Institut National de la Santé et de la Recherche Médicale INSERM U795, Faculte de Medecine, Lille, France
Int J Tuberc Lung Dis 14:471-81. 2010
....
ABCB1 allele polymorphism is associated with virological efficacy in naïve HIV-infected patients on HAART containing nonboosted PIs but not boosted PIsX De La Tribonniere
Infectious Diseases Department, Tourcoing Hospital, Tourcoing, France
HIV Clin Trials 9:192-201. 2008
..To assess the effect of the multidrug resistance-1 single nucleotide polymorphism (ABCB1 SNP) C3435T in exon 26 on the virological responses to first-line protease inhibitor (PI)-containing HAART regimens...
Safety of prolonged high-dose levofloxacin therapy for bone infectionsE Senneville
Infectious Disease Department, Dron Hospital, Tourcoing, France
J Chemother 19:688-93. 2007
..001, respectively). A dosage of 750 mg q.d. may be warranted for prolonged high-dose levofloxacin treatment in patients with bone infections rather than 500 mg b.i.d. for the entire duration of treatment, or for the first 3 weeks...
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentE Pukenyte
Department of Infectious Diseases, Centre Hospitalier de Tourcoing, Tourcoing, France
Int J Tuberc Lung Dis 11:78-84. 2007
....
Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudineLaurence Bocket
Service Universitaire de Virologie, Centre Hospitalier Regional de Lille, Lille, France
J Antimicrob Chemother 53:89-94. 2004
....
Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithmsKaren Champenois
CRESGE LEM CNRS, Lille, France
AIDS 22:1087-9. 2008
....
Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trialsM Pichenot
Department of Infectious Diseases, Hospital of Tourcoing, Tourcoing, France
HIV Med 13:148-55. 2012
..We compared CD4 cell count increases associated with chemokine (C-C motif) receptor 5 (CCR5) inhibitors or other new drugs, using indirect comparison...
Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort studyL Legout
Infectious Diseases Department, rue du Président Coty, 59208 Tourcoing, France
Clin Microbiol Infect 18:352-8. 2012
..Overall in-hospital mortality was 16.5% (n=14). Two variables were independently associated with mortality: age >70 years (OR 9.1, 95% CI 1.83-45.43, p 0.007) and aortic graft infection (OR 5.6, 95% CI 1.1-28.7, p 0.037)...
Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of NigeriaH Melliez
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France
Vaccine 25:298-305. 2007
..In this study in a sub-Saharan country, we showed that rotavirus vaccination with a new vaccine substantially reduces the number of deaths from rotavirus diarrhoea and may be of great use in developing countries...
[Pneumonia in a traveller coming back from Asia]S Nguyen
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 135, rue du Président Coty, 59208 Tourcoing, France
Med Mal Infect 38:667-70. 2008
..Furthermore, choosing an empiric antibiotic treatment with fluoroquinolones could lead to treatment failure if the patient traveled in a country where fluoroquinolone resistance is high, as in Asia and especially in India...
Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infectionVéronique Pancré
UMR 8527 CNRS Lille II Institut Pasteur de Lille, Institut de Biologie, Lille, France
Vaccine 25:5927-37. 2007
..So, early good T CD4 response to peptides of the Nef protein could thus be regarded as a factor of good prognosis in HIV infection and a tool of importance in the decision to put or not a patient under treatment...
Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modellingSylvie Deuffic-Burban
CTRS, Unité INSERM 795, Hôpital Swynghedauw, CHRU de Lille, Lille, France
Eur J Epidemiol 22:737-44. 2007
..All of the models indicate that the overall incidence of opportunistic infections under HAART in sub-Saharan Africa is high. This suggests that prophylaxis against opportunistic infections may be needed even for patients receiving HAART...
Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infectionsM Mallet
Infectious Diseases Department, Dron Hospital, Tourcoing, France
Infection 39:473-6. 2011
..To evaluate the role of Staphylococcus simulans in bone and joint infections (BJI) and determine their main characteristics...
Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitisJ Poissy
Service Universitaire des Maladies Infectieuses et du Voyageur, Tourcoing, France
Clin Microbiol Infect 15:560-4. 2009
..8%), and three in six (3.3%). Patients with HSE often present with severe underlying disease, chronic alcohol abuse, or atypical CSF findings, and such factors should not be allowed to delay diagnosis and administration of acyclovir...
Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysisN Penel
Département de Cancérologie Générale, Centre Oscar Lambret, Lille, France
Int J Oral Maxillofac Surg 37:135-9. 2008
..These results support the application of preventive interventions to reduce nosocomial infections in this setting...
Increased bleeding in HIV-positive haemophiliac patients treated with lopinavir-ritonavirYazdan Yazdanpanah
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, , France
AIDS 17:2397-9. 2003
Costs associated with combination antiretroviral therapy in HIV-infected patientsYazdan Yazdanpanah
, Centre Hospitalier de Tourcoing, , 135, , F 59208 Tourcoing
J Antimicrob Chemother 53:558-61. 2004
..More refined cost-effectiveness analyses are needed to evaluate available HIV/AIDS prevention, treatment, and care, and to identify the interventions that provide the best value for money...
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescriptionV Colombié
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier Régional de Tourcoing, Faculté de Lille, Lille
Int J STD AIDS 23:865-9. 2012
..81/day/person) to (33.12; P < 0.0001). Cost should be considered when choosing a first cART regimen, especially when considering clinically equivalent regimens...
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosisN Viget
Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France
Gut 57:549-58. 2008
..In the absence of national and international recommendations, the information given here should help doctors to optimise patient outcomes...
[Pneumonia with septicemia caused by Pasteurella multocida in an immunocompetent patient]E Pukenyte
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59208 Tourcoing, France
Med Mal Infect 37:354-6. 2007
..Furthermore, severe infections caused by this pathogen can occur in immunocompetent patients, so that the implication of specific host factors in the severity of the disease can be suspected. Genetic features could be one of these...
[CCR5 antagonists: a new class of antiretrovirals]X De La Tribonniere
Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier Gustave Dron, Tourcoing, France
Med Mal Infect 38:S1-6. 2008
....
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combinationL Legout
Division of Infectious Diseases, University of Lille, Dron Hospital, Tourcoing, France
Clin Microbiol Infect 12:1030-3. 2006
..The results of the study confirmed the safety and effectiveness of cefepime combined with a fluoroquinolone for the treatment of bone and joint infections caused by Gram-negative bacilli...
Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-upBakhao Ndiaye
CIRE Nord, Lille, Cedex, France
AIDS 23:1786-9. 2009
..Upon returning to care, 33 out of 74 patients (44.6%) had CD4 cell counts less than 200/mm and/or AIDS. Patients who returned to care after LTFU were five times more likely to die than patients who attended clinic regularly...
Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006Bakhao Ndiaye
CIRE Nord, Lille, France
Antivir Ther 14:567-75. 2009
..Our goal was to determine the incidence rate and risk factors for loss to follow-up (LTFU) of HIV-infected patients in Northern France...
Impact of viral eradication on mortality related to hepatitis C: a modeling approach in FranceSylvie Deuffic-Burban
CTRS INSERM U795, CHRU Lille, Lille, France
J Hepatol 49:175-83. 2008
..In France, two recent studies enabled modeling of the impact of viral eradication on HCV mortality...
Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatmentYann Gerard
Service Regional Universitaire des Maladies Infectieuses et du Voyageur, Hôpital Dron, Tourcoing, France
Therapie 58:153-8. 2003
..The early diagnosis of cases was the result of great vigilance and, combined with routine measurements of the anion gap, might be the most crucial factor explaining the low mortality rate observed here...
Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the footEric Senneville
Diabetic Foot Clinic, Gustave Dron Hospital, Tourcoing, France
Clin Infect Dis 48:888-93. 2009
..However, no studies have compared needle puncture with concomitant transcutaneous bone biopsy, which is the current standard recommended in international guidelines...
Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort studyEric Senneville
Diabetic Foot Clinic, Dron Hospital, Tourcoing, France
Diabetes Care 31:637-42. 2008
..The purpose of this article was to identify criteria predictive of remission in nonsurgical treatment of diabetic foot osteomyelitis...
Factors determining length of the postoperative hospital stay after major head and neck cancer surgeryNicolas Penel
Département de Cancérologie Générale, Centre Oscar Lambret, 3 Rue F Combemale, Lille, France
Oral Oncol 44:555-62. 2008
..Two variables (duration of surgical procedure and occurrence of nosocomial infections) were associated with LOS and might be improved by appropriate strategies...
Analysis of costs attributable to an outbreak of severe acute respiratory syndrome at a French hospitalYazdan Yazdanpanah
Infect Control Hosp Epidemiol 27:1282-5. 2006
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan AfricaCharles B Holmes
Division of Infectious Disease, Partners AIDS Research Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Clin Infect Dis 36:652-62. 2003
..Policies regarding the type and timing of opportunistic infection prophylaxis may be region specific and urgently require further study...
Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatmentGeorge M Bahr
Laboratory of Molecular Immunology of Infection and Inflammation, Pasteur Institute of Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille Cedex, France
J Antimicrob Chemother 51:1377-88. 2003
..These results warrant further evaluation of extended periods or cycles of murabutide immunotherapy as adjunct to HAART...
Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed peopleC Delpierre
INSERM U558, IFR126, Toulouse, F 31073, France
Eur J Public Health 18:345-7. 2008
..This population is mainly diagnosed late with major consequences on morbidity and mortality...
Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectivenessLaurence Bocket
Virology Department, Centre Hospitalier Universitaire de Lille, France
Antivir Ther 10:247-54. 2005
..The effectiveness of antiretroviral treatment (ART) was compared in 416 naive patients from a French clinical cohort infected with B and non-B HIV-1 subtypes...
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patientsAlfredo Alberti
J Hepatol 42:615-24. 2005
Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patientsLaure Valerio
Departement de sante publique, Centre Hospitalier Universitaire de Nice, Nice, France
J Acquir Immune Defic Syndr 47:50-5. 2008
..Our objective was to determine if a baseline CD4 count >/=350 cells/mm predicts a sustained HCV response to pegylated interferon plus ribavirin...
[When to initiate antiretroviral therapy and what to start with?]Nathalie Viget
Service régional universitaire des maladies infectieuses, Centre Hospitalier de Tourcoing, 59208, Tourcoing Cedex
Rev Prat 56:953-63. 2006
....
Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimenSimona Pavel
AIDS 21:268-9. 2007
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'IvoireElena Losina
Department of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, MA, USA
Antivir Ther 12:543-51. 2007
..Studies in developed countries have shown highly active antiretroviral therapy (HAART) decreases incidence of severe opportunistic diseases (ODs) in HIV-infected patients beyond that which is expected from changes in CD4+ T-cell count...
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'IvoireSue J Goldie
Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
N Engl J Med 355:1141-53. 2006
..As antiretroviral therapy is increasingly used in settings with limited resources, key questions about the timing of treatment and use of diagnostic tests to guide clinical decisions must be addressed...
HIV drug resistance surveillance for prioritizing treatment in resource-limited settingsRochelle P Walensky
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
AIDS 21:973-82. 2007
..Sentinel testing programs for HIV drug resistance in resource-limited settings can inform policy on antiretroviral therapy (ART) and drug sequencing...
Natural polymorphisms in HIV-1 protease: impact on effectiveness of a first-line lopinavir-containing antiretroviral therapy regimenKaren Champenois
Tourcoing AIDS reference centre, France
J Med Virol 80:1871-9. 2008
..However, polymorphisms may affect ART effectiveness differently in other populations, such as ART-experienced patients and/or patients treated with protease inhibitors other than the one used here...
Scaling up antiretroviral therapy in South Africa: the impact of speed on survivalRochelle P Walensky
The Divisions of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
J Infect Dis 197:1324-32. 2008
..Only 33% of eligible human immunodeficiency virus (HIV)-infected patients in South Africa receive antiretroviral therapy (ART). We sought to estimate the impact of alternative ART scale-up scenarios on patient outcomes from 2007-2012...
Risk factors for early catheter-related infections in cancer patientsNicolas Penel
Department of General Oncology, Oscar Lambret Cancer Center, Lille, France
Cancer 110:1586-92. 2007
..The authors conducted a prospective study to identify the risk factors for developing early catheter-related infection...
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virusHolger J Schunemann
Italian National Cancer Institute Regina Elena, INFORMA Unit, Department of Epidemiology, Istituto Regina Elena, Rome, Italy
Lancet Infect Dis 7:21-31. 2007
..Emergence of other novel influenza A viral subtypes with pandemic potential, or changes in the pathogenicity of H5N1 virus strains, will require an update of these guidelines and WHO will be monitoring this closely...
Introduction of SARS in France, March-April, 2003Jean Claude Desenclos
Département Maladies Infectieuses, Institut de Veille Sanitaire, Saint Maurice, France
Emerg Infect Dis 10:195-200. 2004
..Timely detection, isolation of probable case-patients, and quarantine of their contacts appear to have been effective in preventing the secondary spread of SARS in France...
Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control studyEric Senneville
Infectious Diseases Department, Dron Hospital, 135 rue du Président Coty, 59200 Tourcoing, France
J Antimicrob Chemother 54:798-802. 2004
..The intrinsic properties of the new antibiotic linezolid make it an attractive candidate for the treatment of chronic osteomyelitis. However, data regarding the tolerance of long-term linezolid administration are still lacking...
Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective studyEric Senneville
Infectious Diseases Department, Dron Hospital of Tourcoing, 135 rue du Président Coty, 59200 Tourcoing, France
Clin Ther 28:1155-63. 2006
..Linezolid is an oxazolidinone agent which is apparently well designed for treating chronic osteomyelitis, but data on effectiveness and tolerability as prolonged therapy is currently lacking...
Kaposi's sarcoma in HIV-infected patients: when and how should we evaluate bone involvement?Sophie Nguyen
AIDS 21:2251-2. 2007
Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patientsFirouzé Bani-Sadr
AIDS 22:1234-6. 2008